论文部分内容阅读
我们测定了59例Graves’病(GD)患者血中的肿瘤坏死因子(TNF)浓度,现报告于下。 对象和方法 一、对象:GD组均为我院临床确诊病人,年龄21～49岁,给予抗甲状腺药物治疗12～18月后,测血清FT_3、sTSH。恢复正常者38人,未控制者21人。对照组32例,系1996年枣庄市体检健康者,年龄与性别与GD组匹配。 二、方法:TNF试剂盒由解放军总医院东亚免疫技术研究所提供,FT_3、sTSH试剂盒由北京原子能科学院提供,操作按说明书。测量仪器为西安国营262厂生产的PJ-2008P型电脑自动γ计数仪。数据处理采用t检验。
We measured the levels of tumor necrosis factor (TNF) in the blood of 59 patients with Graves’ disease (GD) and are reported below. Subjects and Methods First, the object: GD group are clinically diagnosed patients in our hospital, aged 21 to 49 years old, given anti-thyroid drug treatment after 12 to 18 months, measured serum FT_3, sTSH. 38 were normal, 21 were uncontrolled. The control group of 32 cases, Department of Health in Zaozhuang City in 1996 examination, age and gender and GD group match. Second, the method: TNF kit by the East Asian Institute of Immunization General Hospital of PLA, FT_3, sTSH kit provided by the Beijing Institute of Atomic Energy, according to instructions. Measuring instrument for the 262 state-owned factory in Xi’an PJ-2008P computer automatic γ counter. Data processing using t test.